Boston, Massachusetts

Major Boston-area research context without a verified Boston city enforcement-priority policy. Research activity should be kept separate from local legal status.

State status

Partial decriminalization

This page is not a service-center locator, dispensary directory, vendor list, or purchasing guide. State-level frameworks do not change federal controlled-substance status.

What local context does not answer

Local context can explain policy history, state rules, city ordinances, public-health resources, and community support. It cannot determine whether a substance is safe, effective, lawful for a specific person, available through a specific channel, or appropriate for any individual.

Is it legal for me? Legal status depends on substance, activity, jurisdiction, date, and official source.

Can I buy it? Commercial access is separate from legal status and is not addressed here.

Is it safe? Safety depends on medical history, medications, psychiatric risk, dose, and context.

Does it work? Efficacy requires controlled outcome evidence, not location.

Is a source reliable? Source reliability requires independent verification and quality control.

Am I personally eligible? Eligibility depends on program rules, clinician review, and individual facts.

Local policy context

This section summarizes policy context. It is not legal advice or current-law verification.

Boston has significant hospital, university, and biotechnology research context around psychedelics, but no verified municipal enforcement-priority ordinance for entheogenic plants. Boston should therefore be treated as a research-context city, not a local-decriminalization city. Massachusetts voters rejected Question 4 in 2024, so there is also no statewide regulated-access framework.

Research context only Boston-area hospitals and universities are relevant to public research discussion, but research activity does not create legal consumer access.

No verified Boston city policy No Boston municipal enforcement-priority ordinance was verified in this review.

Statewide framework rejected Question 4 failed in November 2024, so Massachusetts did not create the proposed statewide natural-psychedelic-substances framework.

Legal baseline remains state and federal law Psilocybin is listed under Massachusetts Class C controlled-substance law and federal Schedule I law unless handled within lawful research pathways.

Legal and policy timeline

This timeline documents policy and legal history. It does not describe current access options.

Feb 4, 2021Academic
Boston-area research remains separate from municipal policy
Boston-area medical institutions are part of the broader research conversation, but that context should not be described as municipal decriminalization or legal access.source →
Jun 21, 2026Official (city)
No Boston enforcement-priority ordinance verified
Review found no verified Boston city ordinance or resolution making entheogenic-plant enforcement a lowest priority.source →

Research institutions

Listed for local research and academic context only. These institutions are not psilocybin providers, endorsers, or access points, and their presence does not mean services, treatment, clinical eligibility, or access are available.

Brigham and Women's Hospital
Boston Medical Center
Harvard Medical School
Tufts School of Medicine